Thirty Years of Strategic Business Planning Excellence
Sixteen Years of Big Data, Machine Learning, Digital Health & Agentic Artificial Intelligence Experience
The single most prevalent comment we hear from executives contemplating AI adoptions and integrations is they're simply not sure where to begin. That's where we can help! Performance Transformation brings a unique perspective to its clientele. We've navigated a confluence of three decades of Medical Device and Life Science Strategic Business Planning with executive engagements in Big Data, Machine Learning, Remote Patient Monitoring and Digital Health dating back to 2009. In fact, we've spent all of 2025 immersed in Agentic AI projects, developing use cases for complex quotations, manufacturing solutions, Target Product Profiles, custom Quality Systems, and entire design & development ecosystems. This combination of decades long experience with immersive expertise can help you define where you are in your AI journey, where you want to go, and how to get there in a step-by-step, controlled manner.
Elkay Products
Director, Sales & Marketing
1995
STERIS Corporation
Market Manager, Strategic Services
1996
STERIS Corporation
Director, Scientific Services
1997
STERIS Corporation
Vice President, Europe & Mid-East
1999
REVCO Technologies
Vice President, Sales & Marketing
2000
2001
BioPhile, Inc.
Vice President, Sales & Marketing
2001
SalesForce4Hire, LLC
Executive Strategist
2002
2005
2008
Performance Transformation
Founder & Principal,
Fractional & Interim Executive Services
2009
2010
2011
2012
Transformair/Molekule
Chief Operating Officer,
Fractional Executive
2012
HealO Medical
Vice President, Sales & Marketing, Fractional Executive
2012
CareGenesis, Inc.
CEO, Fractional Executive
2014
NanoSurgery Technology
COO, Fractional Executive
2016
REV.1 Engineering
Vice President of Strategic Development,
Fractional Executive
2018
Rapid Commercialization Partners
Chief Strategy Officer - Medtech,
Fractional Executive
2023
AGILf(x)
Vice President of Strategic Development,
Fractional Executive
2025
Strategic Sales Plan - Acquired by CIT Equity.
Healthcare Services - Strategic Business Plan
Turned around revenue regression, $96MM to $115MM in first year of implementation.
Scientific Services - Strategic Launch Plan
New business unit, parsed $16MM from Healthcare, grew to $35MM in 2 years. Cap Equipment sales grew from 7% to 17% CAGR.
Healthcare, Europe & Middle East Strategic Business Plan powered growth from $24MM to $40MM in first year.
Strategic Business Plan
Life Science lab products. Organic growth & acquisitions
REVCO acquires Kendro Lab Products
Revenue grows from $120MM to $330MM, additional tuck in acquisitions of sample repositories and field service businesses.
Strategic Business Plan - Startup, $1.5MM Seed
Spinoff & JV between REVCO, Virginia Tech and the Medical Automation Research Center, University of Virginia.
Inaugural Strategic Business Plan
Custom sales solutions for medical device companies.
Thermo Fisher acquires Kendro/REVCO for $833.5MM in cash.
Company launch - Fractional & Interim Strategic Executive Services.
First Big Data project with UPMC & Bell Labs.
Market strategy for integration of OR data streams.
Machine Learning project with TalentSprocket.
"The Transformational Entrepreneur" published.
Reflections on successful strategic planning & leadership.
"The Transformational Entrepreneur"
Cited by The Journal of Economic Literature for its thought leadership in strategic planning and business development.
Inaugural Strategic Business Plan
Strategic plan helped secure $100MM in equity funding.
Inaugural Strategic Business Plan
Helped secure $2.5MM in seed equity funding.
Inaugural Strategic Business Plan
Early remote patient (Alzheimer's) monitoring company.
Pre-money turnaround licensed from the University of Florida, ahead of technology at the time. Secured interest from Florida Funders and New World Angels.
Inaugural Strategic Business Plan
Microinvasive intervention. Raised seed capital from local accredited investors. Brought early prototype work to REV.1 Engineering.
Strategic Business Plan, Sales & Marketing
Ten year old, advanced medical device design & development firm. Helped grow business from a valuation of ≈ $5MM to a cash exit of $25MM in 36 months (to ASAHI-Intecc).
Strategic Development
Tasked with building out fractional executive practice for medical device and technoloy segment.
Strategic Development
Tasked with building out custom AI products business for medical device design, development and manufacturing sectors.
Contact
We're always looking for new and exciting opportunities. Let's connect!
(828) 808-2955